ClinicalTrials.gg
Not yet recruitingNCT06601023PM+MiLEUpdated Sep 19, 2024

Problem Management Plus Mindfulness-informed Legal Education for Addressing Gender-based Violence and Improving Parenting

An interventional study of Psychosocial intervention in Depression, Anxiety, Trauma and Anxiety, sponsored by Teesside University. Not yet recruiting. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Teesside University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Gender-based violence and, more specifically, domestic violence is a prevalent problem globally and in Nigeria. Its effect significantly impacts women and also the wellbeing of their families. Limited access to support has posed a constraint in effectively addressing the issues suffered by affected victims in Nigeria. In addition, gender-based violence could affect parenting due to factors such as anxiety, trauma, depression, poor social support, limited awareness of legal channels for complaint and harsh parenting to children. The implication is that it could not only have a negative impact on the affected victim but also on their parenting styles or caring responsibilities, which could be detrimental to the child development, wellbeing and the potential subsequent resort to criminal behaviours. In essence, the current study aims to test the feasibility and acceptability of a novel cross disciplinary intervention titled, Problem Management plus Mindfulness-informed Legal Education (PM+MiLE) for addressing gender-based violence and improving parenting in Nigeria in comparison to the waitlist control group for the purposes of improving social cohesion, legal awareness, wellbeing and reducing depression, including trauma and anxiety as a result of experiencing gender-based violence, in Nigeria.

02

Conditions studied

  • Depression, Anxiety
  • Trauma
  • Anxiety
  • Parenting Intervention
  • Woman Abuse
  • Child Behaviour
  • Stress

Keywords

  • Depression
  • Stress
  • Anxiety
  • Trauma
  • Gender-based violence
  • Parenting
  • Domestic violence
  • Women
03

In context

Depression

8,577 studies on the registry are indexed under Depression; 1,720 are open to participants now.

This study's planned enrollment of 24 is below the median of 81 across 7,063 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Teesside University is the lead sponsor of 55 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years and above
  • Female with child(ren) or with caring responsibilities for child(ren).
  • Able to provide full consent for their participation.
  • A resident of the study areas (Delta, Jos, Lagos State, etc.)

Exclusion criteria

Exclusion Criteria:

  • Less than 18 years
  • Unable to consent
  • Currently undergoing severe mental healthtreatment
  • Unable to speak the English language fl uently
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Problem Management plus Mindfulness-informed LegalEducation (PM+MiLE)

    The PM+MiLE is a six sessions intervention lasting approximately 90 minutes. A session will be delivered weekly for six week.

    Behavioral: Psychosocial intervention

  • No intervention
    Control - Waitlist Group

    The control group will receive no intervention until after the assessment periods at baseline, end of intervention and 3 months follow up before they will be administered the PM+MiLE.

Interventions

  • BehavioralPsychosocial intervention

    The PM+MiLE is a low-intensity intervention. The intervention will cover relevant aspects of brief mindfulness, legal education, awareness of human rights and challenges of complaint, including support. The problem management ambit will include understanding adversity, managing stress, managing problems, getting going and keep doing, strengthening social support and staying well and looking forward, including positive behaviour modification.The intervention will also incorporate child development and building positive parenting interactions with children.

06

What researchers measure

Primary outcomes

  1. Service Satisfaction Scale

    A five item scale that can be used to assess and measure satisfaction, acceptability and quality of the intervention. Higher score denote positive outcomes and acceptability. Lower score denotes poor satisfaction and acceptability.

    Time frame: 6 weeks at the end of intervention

Secondary outcomes

  1. Gender-based Violence, Stress and Parenting Scale

    The scale is a 4 item scale that will be use for assessing and measuring gender-based violence, stress and parenting. The scale has an overall rating of 20 with score ranging 1-5 indicating severe stress in parenting, 5-10 indicating moderately severe stress in parenting, 11-15 mild stress in parenting and 16- 20 no stress in parenting.

    Time frame: Baseline, end of intervention and 3 months post intervention.

  2. Post-traumatic Stress Disorder Checklist (PCL-5)

    The PCL-5 is a 20-item self-report measure that can be used to assess the 20 DSM-5 symptoms of post traumatic stress disorder. A 5-10 point change represents reliable change (i.e., change not due to chance) and a 10-20 point change represents clinically significant change.

    Time frame: Baseline, 6 weeks end of intervention and 3 months post intervention.

  3. Generalised Anxiety Disorder (GAD-7)

    The GAD-7 is a seven item scale for screening, measuring and assessing the severity of generalised anxiety disorder. Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate and severe anxiety, respectively.

    Time frame: Baseline, 6 weeks end of intervention and 3 months post intervention.

  4. Oslo Social Support Scale (OSSS-3)

    The scale is a 3-item self-reported measure designed for assessing and measuring the level of social support. The sum score ranges from 3 to 14, with high values representing strong levels and low values representing poor levels of social support as indicated as follows: a) 3-8 poor social support, b) 9-11 moderate social support, c) 12-14 strong social support.

    Time frame: Baseline, 6 weeks end of intervention and 3 months post intervention.

  5. Legal-informed Awareness of Complaint Channel Scale (LACCS)

    The LACCS is a 10-item scale that is designed for assessing and measuring level of awareness of complaint channels and legal rights. The scale has an overall rating of 30, with 0-7 indicating poor knowledge, 8-15 (average knowledge), 16-22 (good knowledge) and 23-30 (excellent knowledge).

    Time frame: Baseline, 6 weeks end of intervention and 3 months post intervention.

  6. Harsh Parenting Scale

    The scale is a 4 item scale use to assess harsh parenting. The scale has a rating of 20 with lower scores indicating non harsh parenting and higher scores indicating severe harsh parenting.

    Time frame: Baseline, 6 weeks end of intervention and 3 months post intervention.

  7. Parenting Stress Scale

    The PSS is an 18-item questionnaire for assessing parents' feelings about their parenting role, exploring both positive aspects (e.g. personal development, emotional benefits,) and negative aspects of parenthood (e.g. demands on resources, and feelings of stress). Parental stress scores range from 18 to 90, with lower scores indicating lower levels of parental stress.

    Time frame: Baseline, 6 weeks end of intervention and 3 months post intervention.

  8. European Quality of Life Scale EQ-5D-5L

    The EQ-5D-5L is a 5 item scale designed to aid assessment of the generic quality of life. In the EQ-5D-5L, each dimension has five response levels: no problems (Level 1); slight (Level 2); moderate (Level 3); severe (Level 4); and extreme problems (Level 5). There are 3,125 possible health states defined by combining one level from each dimension, ranging from 11111 (full health) to 55555 (worst health).

    Time frame: Baseline, 6 weeks end of intervention and 3 months post intervention.

  9. Patient Health Questionnaire (PHQ-9)

    This The Patient Health Questionnaire (PHQ-9) is a 9-item questionnaire that will be used for screening, monitoring, measuring and assessing the severity of depression. Low scores (e.g. 0-4) indicate no depression, however, higher scores (20-27) indicates severe depression.

    Time frame: Baseline, 6 weeks end of intervention and 3 months post intervention.

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Oladepo O, Yusuf OB, Arulogun OS. Factors influencing gender based violence among men and women in selected states in Nigeria. Afr J Reprod Health. 2011 Dec;15(4):78-86. PubMed 22571109 ↗
  • Aborisade, R.A., (2024). Violence In A Patriarchal Nigerian Society. Routledge International Handbook of Investigative Interviewing and Interrogation, p.372.

Individual participant data

Plan to share: No — Data supporting this study cannot be made available due to the sensitive nature and ethical reasons on confidentiality.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2024; primary completion for May 2025, 8 months later.

Of 3,468 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 8 months is below that.

Counting every sponsor, half of 3,566 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 14, 2024
First posted
Sep 19, 2024
StartEst.
Sep 24, 2024
Primary completionEst.
May 30, 2025
CompletionEst.
Jun 30, 2025
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06601023
Lead sponsor
Teesside University
Collaborators
Jos University Teaching Hospital, University of Manchester
Responsible party
Tarela Ike (Senior Lecturer and Principal Investigator, Teesside University) — Principal investigator
First posted
Sep 19, 2024
Start date
Sep 24, 2024 (estimated)
Primary completion
May 30, 2025 (estimated)
Completion
Jun 30, 2025 (estimated)
Last update
Sep 19, 2024

Study contacts

Tarela J. Ike, Dr
Contact
T.Ike@tees.ac.uk
016-423-4231
Dung E Jidong, Dr
Contact
Dung.Jidong@manchester.ac.uk

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion